The global Biotherapeutics Cell Line Development market size was valued at USD 402 million in 2023 and is forecast to a readjusted size of USD 601.9 million by 2030 with a CAGR of 5.9% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Biotherapeutics Cell Line Development industry chain, the market status of In-house (Transfection & Selection, Single Cell Cloning), Outsource (Transfection & Selection, Single Cell Cloning), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biotherapeutics Cell Line Development.
Regionally, the report analyzes the Biotherapeutics Cell Line Development markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biotherapeutics Cell Line Development market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biotherapeutics Cell Line Development market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biotherapeutics Cell Line Development industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Transfection & Selection, Single Cell Cloning).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biotherapeutics Cell Line Development market.
Regional Analysis: The report involves examining the Biotherapeutics Cell Line Development market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biotherapeutics Cell Line Development market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biotherapeutics Cell Line Development:
Company Analysis: Report covers individual Biotherapeutics Cell Line Development players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biotherapeutics Cell Line Development This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (In-house, Outsource).
Technology Analysis: Report covers specific technologies relevant to Biotherapeutics Cell Line Development. It assesses the current state, advancements, and potential future developments in Biotherapeutics Cell Line Development areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biotherapeutics Cell Line Development market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biotherapeutics Cell Line Development market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Transfection & Selection
Single Cell Cloning
Market segment by Application
In-house
Outsource
Hybrid
Do-It-Yourself (DIY)
Market segment by players, this report covers
Becton Dickinson & Company
Beckman Coulter
Boehringer Ingelheim Group
Catalent Inc.
CMC Biologics A/S
Lonza Group Ltd.
EMD Millipore
Partec (Sysmex Corporation)
ProBioGen AG
Selexis SA
Sigma-Aldrich Co. LLC.
Sony Biotechnology Inc.
Thermo Fisher Scientific Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biotherapeutics Cell Line Development product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biotherapeutics Cell Line Development, with revenue, gross margin and global market share of Biotherapeutics Cell Line Development from 2019 to 2024.
Chapter 3, the Biotherapeutics Cell Line Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biotherapeutics Cell Line Development market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biotherapeutics Cell Line Development.
Chapter 13, to describe Biotherapeutics Cell Line Development research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Biotherapeutics Cell Line Development
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biotherapeutics Cell Line Development by Type
1.3.1 Overview: Global Biotherapeutics Cell Line Development Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biotherapeutics Cell Line Development Consumption Value Market Share by Type in 2023
1.3.3 Transfection & Selection
1.3.4 Single Cell Cloning
1.4 Global Biotherapeutics Cell Line Development Market by Application
1.4.1 Overview: Global Biotherapeutics Cell Line Development Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 In-house
1.4.3 Outsource
1.4.4 Hybrid
1.4.5 Do-It-Yourself (DIY)
1.5 Global Biotherapeutics Cell Line Development Market Size & Forecast
1.6 Global Biotherapeutics Cell Line Development Market Size and Forecast by Region
1.6.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biotherapeutics Cell Line Development Market Size by Region, (2019-2030)
1.6.3 North America Biotherapeutics Cell Line Development Market Size and Prospect (2019-2030)
1.6.4 Europe Biotherapeutics Cell Line Development Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biotherapeutics Cell Line Development Market Size and Prospect (2019-2030)
1.6.6 South America Biotherapeutics Cell Line Development Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biotherapeutics Cell Line Development Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Becton Dickinson & Company
2.1.1 Becton Dickinson & Company Details
2.1.2 Becton Dickinson & Company Major Business
2.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Product and Solutions
2.1.4 Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Becton Dickinson & Company Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Biotherapeutics Cell Line Development Product and Solutions
2.2.4 Beckman Coulter Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Boehringer Ingelheim Group
2.3.1 Boehringer Ingelheim Group Details
2.3.2 Boehringer Ingelheim Group Major Business
2.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product and Solutions
2.3.4 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer Ingelheim Group Recent Developments and Future Plans
2.4 Catalent Inc.
2.4.1 Catalent Inc. Details
2.4.2 Catalent Inc. Major Business
2.4.3 Catalent Inc. Biotherapeutics Cell Line Development Product and Solutions
2.4.4 Catalent Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Catalent Inc. Recent Developments and Future Plans
2.5 CMC Biologics A/S
2.5.1 CMC Biologics A/S Details
2.5.2 CMC Biologics A/S Major Business
2.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Product and Solutions
2.5.4 CMC Biologics A/S Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CMC Biologics A/S Recent Developments and Future Plans
2.6 Lonza Group Ltd.
2.6.1 Lonza Group Ltd. Details
2.6.2 Lonza Group Ltd. Major Business
2.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Product and Solutions
2.6.4 Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Lonza Group Ltd. Recent Developments and Future Plans
2.7 EMD Millipore
2.7.1 EMD Millipore Details
2.7.2 EMD Millipore Major Business
2.7.3 EMD Millipore Biotherapeutics Cell Line Development Product and Solutions
2.7.4 EMD Millipore Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 EMD Millipore Recent Developments and Future Plans
2.8 Partec (Sysmex Corporation)
2.8.1 Partec (Sysmex Corporation) Details
2.8.2 Partec (Sysmex Corporation) Major Business
2.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product and Solutions
2.8.4 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Partec (Sysmex Corporation) Recent Developments and Future Plans
2.9 ProBioGen AG
2.9.1 ProBioGen AG Details
2.9.2 ProBioGen AG Major Business
2.9.3 ProBioGen AG Biotherapeutics Cell Line Development Product and Solutions
2.9.4 ProBioGen AG Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ProBioGen AG Recent Developments and Future Plans
2.10 Selexis SA
2.10.1 Selexis SA Details
2.10.2 Selexis SA Major Business
2.10.3 Selexis SA Biotherapeutics Cell Line Development Product and Solutions
2.10.4 Selexis SA Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Selexis SA Recent Developments and Future Plans
2.11 Sigma-Aldrich Co. LLC.
2.11.1 Sigma-Aldrich Co. LLC. Details
2.11.2 Sigma-Aldrich Co. LLC. Major Business
2.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product and Solutions
2.11.4 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sigma-Aldrich Co. LLC. Recent Developments and Future Plans
2.12 Sony Biotechnology Inc.
2.12.1 Sony Biotechnology Inc. Details
2.12.2 Sony Biotechnology Inc. Major Business
2.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product and Solutions
2.12.4 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sony Biotechnology Inc. Recent Developments and Future Plans
2.13 Thermo Fisher Scientific Inc.
2.13.1 Thermo Fisher Scientific Inc. Details
2.13.2 Thermo Fisher Scientific Inc. Major Business
2.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product and Solutions
2.13.4 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biotherapeutics Cell Line Development Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biotherapeutics Cell Line Development by Company Revenue
3.2.2 Top 3 Biotherapeutics Cell Line Development Players Market Share in 2023
3.2.3 Top 6 Biotherapeutics Cell Line Development Players Market Share in 2023
3.3 Biotherapeutics Cell Line Development Market: Overall Company Footprint Analysis
3.3.1 Biotherapeutics Cell Line Development Market: Region Footprint
3.3.2 Biotherapeutics Cell Line Development Market: Company Product Type Footprint
3.3.3 Biotherapeutics Cell Line Development Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Biotherapeutics Cell Line Development Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biotherapeutics Cell Line Development Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Biotherapeutics Cell Line Development Consumption Value Market Share by Application (2019-2024)
5.2 Global Biotherapeutics Cell Line Development Market Forecast by Application (2025-2030)
6 North America
6.1 North America Biotherapeutics Cell Line Development Consumption Value by Type (2019-2030)
6.2 North America Biotherapeutics Cell Line Development Consumption Value by Application (2019-2030)
6.3 North America Biotherapeutics Cell Line Development Market Size by Country
6.3.1 North America Biotherapeutics Cell Line Development Consumption Value by Country (2019-2030)
6.3.2 United States Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
6.3.3 Canada Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
6.3.4 Mexico Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Biotherapeutics Cell Line Development Consumption Value by Type (2019-2030)
7.2 Europe Biotherapeutics Cell Line Development Consumption Value by Application (2019-2030)
7.3 Europe Biotherapeutics Cell Line Development Market Size by Country
7.3.1 Europe Biotherapeutics Cell Line Development Consumption Value by Country (2019-2030)
7.3.2 Germany Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
7.3.3 France Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
7.3.5 Russia Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
7.3.6 Italy Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Biotherapeutics Cell Line Development Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biotherapeutics Cell Line Development Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region
8.3.1 Asia-Pacific Biotherapeutics Cell Line Development Consumption Value by Region (2019-2030)
8.3.2 China Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
8.3.3 Japan Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
8.3.4 South Korea Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
8.3.5 India Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
8.3.7 Australia Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
9 South America
9.1 South America Biotherapeutics Cell Line Development Consumption Value by Type (2019-2030)
9.2 South America Biotherapeutics Cell Line Development Consumption Value by Application (2019-2030)
9.3 South America Biotherapeutics Cell Line Development Market Size by Country
9.3.1 South America Biotherapeutics Cell Line Development Consumption Value by Country (2019-2030)
9.3.2 Brazil Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
9.3.3 Argentina Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Biotherapeutics Cell Line Development Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biotherapeutics Cell Line Development Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country
10.3.1 Middle East & Africa Biotherapeutics Cell Line Development Consumption Value by Country (2019-2030)
10.3.2 Turkey Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
10.3.4 UAE Biotherapeutics Cell Line Development Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Biotherapeutics Cell Line Development Market Drivers
11.2 Biotherapeutics Cell Line Development Market Restraints
11.3 Biotherapeutics Cell Line Development Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Biotherapeutics Cell Line Development Industry Chain
12.2 Biotherapeutics Cell Line Development Upstream Analysis
12.3 Biotherapeutics Cell Line Development Midstream Analysis
12.4 Biotherapeutics Cell Line Development Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Becton Dickinson & Company
Beckman Coulter
Boehringer Ingelheim Group
Catalent Inc.
CMC Biologics A/S
Lonza Group Ltd.
EMD Millipore
Partec (Sysmex Corporation)
ProBioGen AG
Selexis SA
Sigma-Aldrich Co. LLC.
Sony Biotechnology Inc.
Thermo Fisher Scientific Inc.
听
听
*If Applicable.
